Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19
Open Access
- 22 October 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 10, 563850
Abstract
There is abundant evidence that the innate immune response to influenza A virus (IAV) is highly complex and plays a key role in protection against IAV induced infection and illness. Unfortunately it also clear that aspects of innate immunity can lead to severe morbidity or mortality from IAV, including inflammatory lung injury, bacterial superinfection, and exacerbation of reactive airways disease. We review broadly the virus and host factors that result in adverse outcomes from IAV and show evidence that inflammatory responses can become damaging even apart from changes in viral replication per se, with special focus on the positive and adverse effects of neutrophils and monocytes. We then evaluate in detail the role of soluble innate inhibitors including surfactant protein D and antimicrobial peptides that have a potential dual capacity for down-regulating viral replication and also inhibiting excessive inflammatory responses and how these innate host factors could possibly be harnessed to treat IAV infection. Where appropriate we draw comparisons and contrasts the SARS-CoV viruses and IAV in an effort to point out where the extensive knowledge existing regarding severe IAV infection could help guide research into severe COVID 19 illness or vice versa.Keywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 183 references indexed in Scilit:
- Cationic Host Defence Peptides: Potential as Antiviral TherapeuticsBioDrugs, 2013
- IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) VirusCell Research, 2011
- Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza PneumonitisThe American Journal of Pathology, 2011
- The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D bindingVirology, 2011
- Inflammasomes as mediators of immunity against influenza virusTrends in Immunology, 2011
- A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola VirusJournal of Biological Chemistry, 2010
- Human β‐defensin 3 has immunosuppressive activity in vitro and in vivoEuropean Journal of Immunology, 2010
- Influenza virus activates inflammasomes via its intracellular M2 ion channelNature Immunology, 2010
- The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1Immunity, 2009
- Expression of the 1918 Influenza A Virus PB1-F2 Enhances the Pathogenesis of Viral and Secondary Bacterial PneumoniaCell Host & Microbe, 2007